Advances in Biology and Therapy of Multiple Myeloma Volume 2: Translational and Clinical Research /
Despite the advances in conventional, and novel agent and high dose chemotherapy, multiple myeloma remains incurable. In order to overcome resistance to current therapies and improve patient outcome, novel biologically-based treatment approaches are being developed. Current translational research in...
Saved in:
| Corporate Author: | |
|---|---|
| Other Authors: | , |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
New York, NY :
Springer New York : Imprint: Springer,
2013.
|
| Edition: | 1st ed. 2013. |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/978-1-4614-5260-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- T cell responses in myeloma
- Novel antigenic targets for immunotherapy in myeloma
- Antibody-based therapies in Multiple Myeloma
- Defining multiple myeloma as a target for DNA gene fusion vaccines
- Harnessing allogeneic immunity for anti-myeloma response
- Dendritic cell and peptide-based vaccination in myeloma
- New Proteasome inhibitors
- Newer Imids
- New agents in myeloma
- Early Combination Studies in MM
- The effect of novel antimyeloma agents on bone metabolism
- Index.



